517 related articles for article (PubMed ID: 33995028)
1. Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials.
Franzin R; Stasi A; Ranieri E; Netti GS; Cantaluppi V; Gesualdo L; Stallone G; Castellano G
Front Pharmacol; 2021; 12():630419. PubMed ID: 33995028
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.
Wang WJ; Cai GY; Chen XM
Oncotarget; 2017 Sep; 8(38):64520-64533. PubMed ID: 28969091
[TBL] [Abstract][Full Text] [Related]
3. Senolytics: A Translational Bridge Between Cellular Senescence and Organismal Aging.
Thoppil H; Riabowol K
Front Cell Dev Biol; 2019; 7():367. PubMed ID: 32039197
[TBL] [Abstract][Full Text] [Related]
4. Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction.
Suda M; Paul KH; Tripathi U; Minamino T; Tchkonia T; Kirkland JL
Endocr Rev; 2024 Mar; ():. PubMed ID: 38500373
[TBL] [Abstract][Full Text] [Related]
5. The role of cellular senescence in ageing and endocrine disease.
Khosla S; Farr JN; Tchkonia T; Kirkland JL
Nat Rev Endocrinol; 2020 May; 16(5):263-275. PubMed ID: 32161396
[TBL] [Abstract][Full Text] [Related]
6. Kidney Aging and Chronic Kidney Disease.
Zhang Y; Yu C; Li X
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928291
[TBL] [Abstract][Full Text] [Related]
7. An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence.
Riviere-Cazaux C; Carlstrom LP; Neth BJ; Olson IE; Rajani K; Rahman M; Ikram S; Mansour MA; Mukherjee B; Warrington AE; Short SC; von Zglinicki T; Brown DA; Burma S; Tchkonia T; Schafer MJ; Baker DJ; Kizilbash SH; Kirkland JL; Burns TC
NPJ Precis Oncol; 2023 Nov; 7(1):126. PubMed ID: 38030881
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence and kidney aging.
Rex N; Melk A; Schmitt R
Clin Sci (Lond); 2023 Dec; 137(24):1805-1821. PubMed ID: 38126209
[TBL] [Abstract][Full Text] [Related]
9. Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications:
Kumar M; Yan P; Kuchel GA; Xu M
JACC Basic Transl Sci; 2024 Apr; 9(4):522-534. PubMed ID: 38680957
[TBL] [Abstract][Full Text] [Related]
10. Profiling microRNA expression during senescence and aging: mining for a diagnostic tool of senescent-cell burden.
Weigl M; Krammer TL; Pultar M; Wieser M; Chaib S; Suda M; Diendorfer A; Khamina-Kotisch K; Giorgadze N; Pirtskhalava T; Johnson KO; Inman CL; Xue A; Lämmermann I; Meixner B; Wang L; Xu M; Grillari R; Ogrodnik M; Tchkonia T; Hackl M; Kirkland JL; Grillari J
bioRxiv; 2024 Apr; ():. PubMed ID: 38645053
[TBL] [Abstract][Full Text] [Related]
11. Senescence and tissue fibrosis: opportunities for therapeutic targeting.
O'Reilly S; Tsou PS; Varga J
Trends Mol Med; 2024 Jun; ():. PubMed ID: 38890028
[TBL] [Abstract][Full Text] [Related]
12. Vascular Aging and Atherosclerosis: A Perspective on Aging.
Ma S; Xie X; Yuan R; Xin Q; Miao Y; Leng SX; Chen K; Cong W
Aging Dis; 2024 Mar; ():. PubMed ID: 38502584
[TBL] [Abstract][Full Text] [Related]
13. Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?
Rybtsova N; Berezina T; Kagansky A; Rybtsov S
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33333870
[TBL] [Abstract][Full Text] [Related]
14. Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair.
Mylonas KJ; O'Sullivan ED; Humphries D; Baird DP; Docherty MH; Neely SA; Krimpenfort PJ; Melk A; Schmitt R; Ferreira-Gonzalez S; Forbes SJ; Hughes J; Ferenbach DA
Sci Transl Med; 2021 May; 13(594):. PubMed ID: 34011625
[TBL] [Abstract][Full Text] [Related]
15. The Senolytic Drug JQ1 Removes Senescent Cells via Ferroptosis.
Go S; Kang M; Kwon SP; Jung M; Jeon OH; Kim BS
Tissue Eng Regen Med; 2021 Oct; 18(5):841-850. PubMed ID: 34003467
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and Cancer: The Epidemiological and Metabolic Associations.
Zhang C; Le A
Adv Exp Med Biol; 2021; 1311():217-227. PubMed ID: 34014546
[TBL] [Abstract][Full Text] [Related]
17. Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms.
Wu M; Xu H; Liu J; Tan X; Wan S; Guo M; Long Y; Xu Y
J Diabetes Res; 2021; 2021():6673525. PubMed ID: 34007848
[TBL] [Abstract][Full Text] [Related]
18. Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria.
Masadeh MM; Alzoubi KH; Masadeh MM; Aburashed ZO
Clin Pharmacol; 2021; 13():83-90. PubMed ID: 34007223
[TBL] [Abstract][Full Text] [Related]
19. SGLT-2 inhibitor intervention in diabetes mellitus patients can reduce the incidence of renal injury and adverse events.
Tao X; Pan T; Zhong X; Du Y; Zhang P
Am J Transl Res; 2021; 13(4):2731-2737. PubMed ID: 34017435
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies.
Hua S; Yang Y; Zou D; Li J; Yan K; Xu Y; Jiang X; Rong X; Ye D
Biomed Pharmacother; 2021 Aug; 140():111685. PubMed ID: 34015585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
